GRam Stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03506113

Recruitment Status : Completed

First Posted : April 23, 2018

Last Update Posted : September 21, 2022

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborators:

Chukyo Hospital

Ebina General Hospital

Hitachi General Hospital

Kansai Medical University

Kansai Medical University Medical Center

Nagasaki University

Saga University

University of the Ryukyus

Wakayama Medical University

Tajima Emergency and Critical Care Medical Center

Sapporo City General Hospital

Information provided by (Responsible Party):

Jumpei Yoshimura, MD, Osaka General Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	June 28, 2020
Actual Study Completion Date :	June 28, 2020

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Yoshimura J, Yamakawa K, Ohta Y, Nakamura K, Hashimoto H, Kawada M, Takahashi H, Yamagiwa T, Kodate A, Miyamoto K, Fujimi S, Morimoto T. Effect of Gram Stain-Guided Initial Antibiotic Therapy on Clinical Response in Patients With Ventilator-Associated Pneumonia: The GRACE-VAP Randomized Clinical Trial. JAMA Netw Open. 2022 Apr 1;5(4):e226136. doi: 10.1001/jamanetworkopen.2022.6136. Erratum In: JAMA Netw Open. 2022 Oct 3;5(10):e2240335.

Yoshimura J, Yamakawa K, Kinoshita T, Ohta Y, Morimoto T. GRam stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) trial: rationale and study protocol for a randomised controlled trial. Trials. 2018 Nov 8;19(1):614. doi: 10.1186/s13063-018-2971-2.

To Top